{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:05:32Z","timestamp":1793822732565,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["403000 & 436797"],"award-info":[{"award-number":["403000 & 436797"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00125-018-4778-9","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T14:39:48Z","timestamp":1544711988000},"page":"448-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":158,"title":["Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study"],"prefix":"10.1007","volume":"62","author":[{"given":"Michele L.","family":"Callisaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Beare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velandai K.","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"4778_CR1","volume-title":"World Alzheimer report","author":"Alzheimer\u2019s Disease International","year":"2014","unstructured":"Alzheimer\u2019s Disease International (2014) World Alzheimer report. Alzheimer\u2019s Disease International, London"},{"issue":"5","key":"4778_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","volume":"42","author":"G Cheng","year":"2012","unstructured":"Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42(5):484\u2013491. \n                    https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02758.x","journal-title":"Intern Med J"},{"issue":"3","key":"4778_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","volume":"2","author":"RH Tuligenga","year":"2014","unstructured":"Tuligenga RH, Dugravot A, Tabak AG et al (2014) Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2(3):228\u2013235. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(13)70192-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"4778_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.2337\/dc12-0746","volume":"36","author":"PJ Spauwen","year":"2013","unstructured":"Spauwen PJ, Kohler S, Verhey FR, Stehouwer CD, van Boxtel MP (2013) Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht aging study. Diabetes Care 36(6):1554\u20131561. \n                    https:\/\/doi.org\/10.2337\/dc12-0746","journal-title":"Diabetes Care"},{"issue":"16","key":"4778_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0000000000003226","volume":"87","author":"KB Rajan","year":"2016","unstructured":"Rajan KB, Arvanitakis Z, Lynch EB et al (2016) Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology 87(16):1681\u20131687. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003226","journal-title":"Neurology"},{"issue":"11","key":"4778_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/M14-0737","volume":"161","author":"AM Rawlings","year":"2014","unstructured":"Rawlings AM, Sharrett AR, Schneider AL et al (2014) Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med 161(11):785\u2013793. \n                    https:\/\/doi.org\/10.7326\/M14-0737","journal-title":"Ann Intern Med"},{"issue":"3","key":"4778_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jalz.2009.01.027","volume":"5","author":"DS Knopman","year":"2009","unstructured":"Knopman DS, Mosley TH, Catellier DJ, Coker LH, Atherosclerosis Risk in Communities Study Brain MRI Study (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 5(3):207\u2013214. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2009.01.027","journal-title":"Alzheimers Dement"},{"issue":"9","key":"4778_CR8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","volume":"69","author":"K Yaffe","year":"2012","unstructured":"Yaffe K, Falvey C, Hamilton N et al (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69(9):1170\u20131175. \n                    https:\/\/doi.org\/10.1001\/archneurol.2012.1117","journal-title":"Arch Neurol"},{"issue":"9","key":"4778_CR9","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc09-2038","volume":"33","author":"AC Nooyens","year":"2010","unstructured":"Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM (2010) Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care 33(9):1964\u20131969. \n                    https:\/\/doi.org\/10.2337\/dc09-2038","journal-title":"Diabetes Care"},{"issue":"1-2","key":"4778_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2014.06.008","volume":"344","author":"LE Wisse","year":"2014","unstructured":"Wisse LE, de Bresser J, Geerlings MI et al (2014) Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes. J Neurol Sci 344(1-2):32\u201336. \n                    https:\/\/doi.org\/10.1016\/j.jns.2014.06.008","journal-title":"J Neurol Sci"},{"issue":"12","key":"4778_CR11","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.2337\/dc13-0143","volume":"36","author":"C Moran","year":"2013","unstructured":"Moran C, Phan TG, Chen J et al (2013) Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 36(12):4036\u20134042. \n                    https:\/\/doi.org\/10.2337\/dc13-0143","journal-title":"Diabetes Care"},{"issue":"7","key":"4778_CR12","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/db14-0348","volume":"63","author":"GJ Biessels","year":"2014","unstructured":"Biessels GJ, Reijmer YD (2014) Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63(7):2244\u20132252. \n                    https:\/\/doi.org\/10.2337\/db14-0348","journal-title":"Diabetes"},{"issue":"13","key":"4778_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1212\/WNL.0000000000000269","volume":"82","author":"RO Roberts","year":"2014","unstructured":"Roberts RO, Knopman DS, Przybelski SA et al (2014) Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82(13):1132\u20131141. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000269","journal-title":"Neurology"},{"issue":"3","key":"4778_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamainternmed.2013.13656","volume":"174","author":"JD Williamson","year":"2014","unstructured":"Williamson JD, Launer LJ, Bryan RN et al (2014) Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med 174(3):324\u2013333. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2013.13656","journal-title":"JAMA Intern Med"},{"issue":"11","key":"4778_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","volume":"10","author":"LJ Launer","year":"2011","unstructured":"Launer LJ, Miller ME, Williamson JD et al (2011) Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 10(11):969\u2013977. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(11)70188-0","journal-title":"Lancet Neurol"},{"issue":"1-2","key":"4778_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2013.06.019","volume":"332","author":"M Kooistra","year":"2013","unstructured":"Kooistra M, Geerlings MI, Mali WP et al (2013) Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study. J Neurol Sci 332(1-2):69\u201374. \n                    https:\/\/doi.org\/10.1016\/j.jns.2013.06.019","journal-title":"J Neurol Sci"},{"issue":"6","key":"4778_CR17","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2337\/dc09-1923","volume":"33","author":"J Bresser de","year":"2010","unstructured":"de Bresser J, Tiehuis AM, van den Berg E et al (2010) Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 33(6):1309\u20131314. \n                    https:\/\/doi.org\/10.2337\/dc09-1923","journal-title":"Diabetes Care"},{"issue":"5","key":"4778_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","volume":"77","author":"S Debette","year":"2011","unstructured":"Debette S, Seshadri S, Beiser A et al (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77(5):461\u2013468. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318227b227","journal-title":"Neurology"},{"issue":"11","key":"4778_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1212\/WNL.0b013e3181f25f06","volume":"75","author":"SG Elderen van","year":"2010","unstructured":"van Elderen SG, de Roos A, de Craen AJ et al (2010) Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75(11):997\u20131002. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181f25f06","journal-title":"Neurology"},{"issue":"1","key":"4778_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2337\/dc12-0555","volume":"36","author":"MA Espeland","year":"2013","unstructured":"Espeland MA, Bryan RN, Goveas JS et al (2013) Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative magnetic resonance imaging studies. Diabetes Care 36(1):90\u201397. \n                    https:\/\/doi.org\/10.2337\/dc12-0555","journal-title":"Diabetes Care"},{"key":"4778_CR21","volume-title":"Neuropsychological assessment","author":"M Lezak","year":"1995","unstructured":"Lezak M (1995) Neuropsychological assessment. Oxford University Press, New York"},{"key":"4778_CR22","volume-title":"A compendium of neuropsychological tests. Administration, norms, and commentary","author":"O Spreen","year":"1998","unstructured":"Spreen O, Strauss E (1998) A compendium of neuropsychological tests. Administration, norms, and commentary. Oxford University Press, New York"},{"key":"4778_CR23","volume-title":"Weschler Adult Intelligence Scale","author":"D Weschler","year":"1997","unstructured":"Weschler D (1997) Weschler Adult Intelligence Scale. Psychological Corporation, New York"},{"issue":"4","key":"4778_CR24","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012) Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61(4):1402\u20131418. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2012.02.084","journal-title":"Neuroimage"},{"issue":"6","key":"4778_CR25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/STROKEAHA.111.647271","volume":"43","author":"P Choi","year":"2012","unstructured":"Choi P, Ren M, Phan TG et al (2012) Silent infarcts and cerebral microbleeds modify the associations of white matter lesions with gait and postural stability: population-based study. Stroke 43(6):1505\u20131510. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.647271","journal-title":"Stroke"},{"issue":"5","key":"4778_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/13645579.2015.1126486","volume":"19","author":"KJ Lee","year":"2016","unstructured":"Lee KJ, Roberts G, Doyle LW, Anderson PJ, Carlin JB (2016) Multiple imputation for missing data in a longitudinal cohort study: a tutorial based on a detailed case study involving imputation of missing outcome data. Int J Soc Res Methodol 19(5):575\u2013591. \n                    https:\/\/doi.org\/10.1080\/13645579.2015.1126486","journal-title":"Int J Soc Res Methodol"},{"key":"4778_CR27","volume-title":"Applied missing data analysis","author":"CK Enders","year":"2010","unstructured":"Enders CK (2010) Applied missing data analysis. Guilford Press, New York"},{"key":"4778_CR28","unstructured":"Muth\u00e9n LK, Muth\u00e9n BO (1998-2018) Mplus user\u2019s guide. Available from \n                    www.statmodel.com\/ugexcerpts.shtml\n                    \n                  . Accessed 14 May 2018"},{"key":"4778_CR29","unstructured":"Asparouhov T, Muth\u00e9n BO (2010) Multiple imputation with Mplus. Available from \n                    www.statmodel.com\/download\/Imputations7.pdf\n                    \n                  . Accessed 14 May 2018"},{"key":"4778_CR30","doi-asserted-by":"publisher","unstructured":"Graham J (2012) Missing data. Springer, New York, \n                    https:\/\/doi.org\/10.1007\/978-1-4614-4018-5","DOI":"10.1007\/978-1-4614-4018-5"},{"issue":"4","key":"4778_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1207\/s15327906mbr3304_5","volume":"33","author":"JL Schafer","year":"1998","unstructured":"Schafer JL, Olsen MK (1998) Multiple imputation for multivariate missing-data problems: a data analyst\u2019s perspective. Multivar Behav Res 33(4):545\u2013571. \n                    https:\/\/doi.org\/10.1207\/s15327906mbr3304_5","journal-title":"Multivar Behav Res"},{"key":"4778_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New York. \n                    https:\/\/doi.org\/10.1002\/9780470316696"},{"key":"4778_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/PRBM.S36238","volume":"9","author":"A Tomlin","year":"2016","unstructured":"Tomlin A, Sinclair A (2016) The influence of cognition on self-management of type 2 diabetes in older people. Psychol Res Behav Manag 9:7\u201320. \n                    https:\/\/doi.org\/10.2147\/PRBM.S36238","journal-title":"Psychol Res Behav Manag"},{"issue":"5","key":"4778_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61(5):661\u2013666. \n                    https:\/\/doi.org\/10.1001\/archneur.61.5.661","journal-title":"Arch Neurol"},{"issue":"1","key":"4778_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000183842","volume":"27","author":"S Maggi","year":"2009","unstructured":"Maggi S, Limongi F, Noale M et al (2009) Diabetes as a risk factor for cognitive decline in older patients. Dement Geriatr Cogn Disord 27(1):24\u201333. \n                    https:\/\/doi.org\/10.1159\/000183842","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"4778_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000083","volume":"29","author":"ER Mayeda","year":"2015","unstructured":"Mayeda ER, Haan MN, Yaffe K, Kanaya AM, Neuhaus J (2015) Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans? Alzheimer Dis Assoc Disord 29(3):206\u2013212. \n                    https:\/\/doi.org\/10.1097\/WAD.0000000000000083","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"4778_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jech-2016-207588","volume":"71","author":"C Pappas","year":"2017","unstructured":"Pappas C, Andel R, Infurna FJ, Seetharaman S (2017) Glycated haemoglobin (HbA1c), diabetes and trajectories of change in episodic memory performance. J Epidemiol Community Health 71(2):115\u2013120. \n                    https:\/\/doi.org\/10.1136\/jech-2016-207588","journal-title":"J Epidemiol Community Health"},{"issue":"3-4","key":"4778_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000366506","volume":"43","author":"ER Mayeda","year":"2014","unstructured":"Mayeda ER, Haan MN, Neuhaus J et al (2014) Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study. Neuroepidemiology 43(3-4):220\u2013227. \n                    https:\/\/doi.org\/10.1159\/000366506","journal-title":"Neuroepidemiology"},{"issue":"6","key":"4778_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1532-5415.2008.01686.x","volume":"56","author":"OI Okereke","year":"2008","unstructured":"Okereke OI, Kang JH, Cook NR et al (2008) Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc 56(6):1028\u20131036. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01686.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"4778_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/jgs.13441","volume":"63","author":"KJ Bangen","year":"2015","unstructured":"Bangen KJ, Gu Y, Gross AL et al (2015) Relationship between type 2 diabetes mellitus and cognitive change in a multiethnic elderly cohort. J Am Geriatr Soc 63(6):1075\u20131083. \n                    https:\/\/doi.org\/10.1111\/jgs.13441","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"4778_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00125-009-1571-9","volume":"53","author":"E Berg van den","year":"2010","unstructured":"van den Berg E, Reijmer YD, de Bresser J et al (2010) A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53(1):58\u201365. \n                    https:\/\/doi.org\/10.1007\/s00125-009-1571-9","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4778-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T20:02:54Z","timestamp":1576180974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4778-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4778"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4778-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"17 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MLC, RB, CM, WW and VKS have no conflicts of interest to declare. TP is on the Genzyme advisory board on Fabry disease, and has received payment for lectures including service on speakers\u2019 bureaus for Bayer, Boehringer Ingelheim, Pfizer and Genzyme.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}